Magically, an Anti-Abortion Study About the Abortion Pill’s ‘Dangers’ Appears
What: A non-peer-reviewed, activist-backed “study” inflated abortion pill complications just after the FDA said it would review new data.
Key Line: “Going to the ER out of caution doesn’t mean a complication occurred.”
Despite lawsuits, Trump admin restored funds to TN and OK while defunding others.
A former NIH director calls for institutional changes to better prioritize female health.
Title X funds withheld due to diversity initiative crackdown, Politico reports.
New York Times honors the woman who funded and enabled the development of the birth control pill.
Cardiology experts warn cutting WHI would jeopardize sex-specific research advances.
ADF targets birth control and IUD coverage in campaign to cut ties with ACOG.
WBUR spotlights MAP volunteers mailing abortion meds to banned states.
Women under 50 are 40% less likely than men to get early transfusions after trauma.
Cosmo breaks down Botox alternatives—and why your injector matters most.
Maternie’s live tracker outlines federal program cuts, including Title X and IVF teams.
A state judge loosens the law—but only slightly—on when abortions can be provided.
A class action lawsuit reveals dangerous conditions at one CPC, prompting ultrasound regulations.
Systemic hormones may worsen incontinence; local therapy helps, study says.
A class action lawsuit reveals dangerous conditions at one CPC, prompting ultrasound regulations.
Maternie’s live tracker outlines federal program cuts, including Title X and IVF teams.
Denied emergency abortion care during miscarriage, a woman sues Catholic hospital in California.
New data shows fertilizing 7–9 eggs is ideal for live births and minimizing excess embryos.
Most menopause-marketed products are rebranded basics—at luxury prices, says Women’s Health investigation.
Interleukin-6 shows early promise in detecting life-threatening sepsis.
Study: Swedish moms with higher-paid parental leave had better mental health postpartum.